US Patent

US9066936 — Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent

Formulation · Assigned to Takeda Pharmaceutical Co Ltd · Expires 2028-03-26 · 2y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a solid pharmaceutical composition containing a specific benzimidazole-7-carboxylate derivative and a pH control agent.

USPTO Abstract

The present invention provides a solid pharmaceutical composition containing compound (I) having an angiotensin II receptor antagonistic action and defined in the specification and a pH control agent, which composition is superior in the stability and dissolution property of compound (I).

Drugs covered by this patent

Patent Metadata

Patent number
US9066936
Jurisdiction
US
Classification
Formulation
Expires
2028-03-26
Drug substance claim
No
Drug product claim
Yes
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.